Product Overview
GHK-Cu 50 mg by Axiolabs is supplied as a vial labeled with 50 mg of copper-binding GHK-Cu. Also known as copper tripeptide or Copper Tripeptide-1, GHK-Cu is a naturally occurring complex formed when the tripeptide glycyl-L-histidyl-L-lysine binds copper. Research interest focuses on skin remodeling, extracellular matrix biology, wound repair and hair-related applications.
Product Class
GHK-Cu is a copper-binding regenerative peptide. It is distinct from anabolic steroids, SARMs, growth-hormone secretagogues and GLP-1 peptides. Its proposed activity is associated primarily with copper transport, cellular signaling and tissue-remodeling pathways.
Indications
GHK-Cu is best established as a cosmetic and dermatologic research ingredient, particularly in skin-care formulations. Experimental research has examined wound healing, collagen remodeling, tissue repair, inflammation and hair biology. Injectable GHK-Cu should not be assumed to have the same regulatory status or evidence base as topical cosmetic Copper Tripeptide-1.
Mechanism of Action
GHK binds copper ions with high affinity and may influence processes involved in tissue remodeling. Experimental work suggests effects on fibroblast activity, collagen and extracellular-matrix production, antioxidant pathways, inflammatory signaling and tissue repair. These mechanisms are considerably different from androgen-receptor or GH/IGF-1 signaling.
Potential Benefits
Research interest includes supporting collagen and elastin remodeling, skin quality, wound-repair processes and hair-follicle biology. GHK-Cu is therefore frequently described as a regenerative or cosmetic peptide. Evidence is stronger for laboratory and topical applications than for systemic peptide administration.
Synergy & Stacking
BPC-157 and TB-500 are commonly discussed alongside GHK-Cu in regenerative-peptide contexts because all three are associated with different aspects of tissue-repair research. BPC-157 is primarily investigated for gastrointestinal, vascular and musculoskeletal repair pathways, while TB-500-related research focuses on cellular migration and tissue remodeling.
GH, Ipamorelin and CJC-1295 are sometimes paired conceptually with GHK-Cu because the GH/IGF-1 axis affects tissue growth and repair. These combinations remain mechanistically based rather than validated GHK-Cu treatment protocols.
HRT/TRT Application
GHK-Cu has no established role in testosterone replacement therapy. It does not supply Testosterone, activate androgen receptors or restore gonadal hormone production. It may be discussed alongside HRT programs for skin or hair goals, but that represents a separate application rather than a component of TRT itself.
Dosing and Use
The Axiolabs product is labeled as containing 50 mg per vial. There is no regulator-approved systemic GHK-Cu dosing regimen for anti-aging, recovery, bodybuilding or hair growth. The 50 mg designation therefore represents stated vial content and should not be interpreted as a recommended single administration or treatment schedule.
Female Use
GHK-Cu is non-androgenic and is not expected to cause anabolic-steroid-type virilization. This makes its pharmacology fundamentally different from Testosterone and other androgens. However, adequate systemic pregnancy and breastfeeding data are lacking.
Comparative Analysis
GHK-Cu vs BPC-157: GHK-Cu is a copper-binding tripeptide associated strongly with extracellular-matrix and skin biology, whereas BPC-157 is an experimental 15-amino-acid peptide investigated primarily in tissue-repair models.
GHK-Cu vs TB-500: GHK-Cu influences copper-dependent regenerative signaling; TB-500-related compounds are associated with thymosin-beta-4 pathways and cellular migration.
GHK-Cu vs HGH: HGH acts through the GH/IGF-1 endocrine axis. GHK-Cu instead functions as a copper-binding signaling peptide and does not stimulate or replace growth hormone.
GHK-Cu vs MOTS-c: MOTS-c is a mitochondrial-derived metabolic peptide associated with cellular energy signaling, whereas GHK-Cu is primarily associated with tissue remodeling and regenerative biology.
Conclusion
GHK-Cu 50 mg by Axiolabs is a copper-binding tripeptide associated with extracellular-matrix remodeling, skin biology and regenerative research. Its mechanism differs substantially from GH peptides, metabolic peptides and anabolic compounds. While Copper Tripeptide-1 has an established presence in cosmetic science, systemic GHK-Cu applications remain less established, and the stated 50 mg vial strength does not constitute a recommended dose.
GHK-CU 50 mg FAQ
What does GHK-Cu stand for?
GHK refers to glycyl-L-histidyl-L-lysine. When this tripeptide binds copper, the resulting complex is commonly called GHK-Cu or copper tripeptide.
Is GHK-Cu the same as Copper Tripeptide-1?
Copper Tripeptide-1 is the cosmetic ingredient terminology commonly associated with the copper complex of GHK.
Is GHK-Cu a growth hormone peptide?
No. It does not stimulate GH through GHRH or ghrelin receptors and should not be classified with Ipamorelin, Sermorelin or CJC-1295.
Is GHK-Cu used for hair?
GHK-Cu appears in hair and scalp research and cosmetic formulations, but this does not establish injectable GHK-Cu as an approved treatment for hair loss.
